Michael Happich is International Health Technology Assessment (HTA) director at Eli Lilly based in Bad Homburg, Germany. He leads a team of HTA & RWE scientists to support international drug launches, HTA submissions and observational research in the autoimmune, pain and neurology...
Read More →